Lymphoma Patients' quality of life under the microscope in new CAR-T study

NCT ID NCT04914091

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 70 adults with diffuse large B-cell lymphoma who are receiving CAR-T cell therapy outside of a clinical trial. Researchers will track patients' quality of life, medication use, and personal feedback over time using questionnaires. The goal is to understand the real-world impact of this expensive, innovative treatment on daily living.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH CART-CELLS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospices Civils de Lyon -Groupement Hospitalier Sud Service pharmaceutique, Unité de Pharmacie Clinique Oncologique

    RECRUITING

    Pierre-Bénite, 69495, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact